SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


   Date of Report (Date of                             Commission File Number:
  earliest event reported):

        MARCH 17, 2000                                         1-10210





                                  EGLOBE, INC.
             (Exact name of registrant as specified in its charter)

          DELAWARE                                        13-3486421
 (State or other jurisdiction of                  (IRS Employer Identification
          incorporation)                                    Number)



                         1250 24TH STREET, NW, SUITE 725
                             WASHINGTON, D.C. 20037
               (Address of principal executive offices) (Zip Code)


               Registrant's telephone number, including area code:
                                 (202) 822-8981


          (Former name or former address, if changed since last report)

                                       NA





<PAGE>


                                  EGLOBE, INC.


ITEM 5            OTHER EVENTS

         On March 17, 2000, we closed a $4 million equity private placement with
RGC International Investors, LDC ("RGC"), which made a $15 million investment in
us on  January  26,  2000.  Pursuant  to  the  terms  of a  securities  purchase
agreement,  we issued  RGC 4,000  shares of our Series Q  convertible  preferred
stock (the "Series Q Preferred Stock") and warrants (the "Series Q Warrants") to
purchase  100,000  shares of our common  stock with a per share  exercise  price
equal to $12.04,  subject to  adjustment  for  issuances of shares of our common
stock below market price. We intend to use the proceeds of the private placement
for general working capital.

         The Series Q securities  purchase  agreement  also provides that we may
issue up to 6,000 additional shares of our Series Q Preferred Stock and warrants
to  purchase  an  additional  150,000  shares of our common  stock to RGC for an
additional $6,000,000 at a second closing to be completed no later than July 15,
2000.  The primary  condition to the second  closing is the  effectiveness  of a
registration  statement  registering  the resale of common stock  underlying the
Series Q Preferred  Stock and the Series Q Warrants and the preferred  stock and
warrants issued in January (the "January Stock and Warrants").

         The shares of Series Q Preferred Stock carry an effective  annual yield
of 5% (payable in kind at the time of conversion)  and are  convertible,  at the
holder's  option,  into shares of common stock. The shares of Series Q Preferred
Stock will  automatically  be converted into shares of common stock on March 15,
2003, subject to delay for specified events. The conversion price for the Series
Q Preferred Stock is $12.04 until April 26, 2000, and thereafter is equal to the
lesser of:

o     the five day average  closing  price of our common stock on Nasdaq  during
      the 22-day period prior to conversion, and

o     $12.04.

We can force a  conversion  of the Series Q  Preferred  Stock on any trading day
following a period in which the  closing bid price of our common  stock has been
greater  than $24.08 for a period of at least 20 trading  days after the earlier
of:

o     the  first  anniversary  of  the  date  the  common  stock  issuable  upon
      conversion  of the  Series Q  Preferred  Stock and  Series Q  Warrants  is
      registered for resale, and

o     the  completion of a firm  commitment  underwritten  public  offering with
      gross proceeds to us of at least $45 million.

         The Series Q Preferred Stock is convertible into a maximum of 3,434,581
shares of common stock.  This maximum share amount is subject to increase if the
average closing bid prices of our common stock for the 20 trading days ending on
the later of June 30,  2000 and the 60th  calendar  day after the  common  stock
issuable upon  conversion of the Series Q Preferred  Stock and Series Q Warrants
is registered is less than $9.375, provided that under no circumstances will the
Series Q Preferred Stock be convertible  into more than 7,157,063  shares of our
common stock (the maximum share amount will increase to 9,365,463  shares of our
common stock if we receive written guidance from Nasdaq that the issuance of the
Series Q Preferred  Stock and the Series Q Warrants will not be integrated  with
the issuances of the January  Stock and  Warrants).  In addition,  no holder may
convert the Series Q Preferred  Stock or exercise  the Series Q Warrants it owns
for any  shares  of common  stock  that  would  cause it to own  following  such
conversion  or exercise in excess of 4.9% of the shares of our common stock then
outstanding.
<PAGE>

         We may be required to redeem the Series Q Preferred Stock under certain
circumstances:

o     if we fail to perform specified  obligations under the securities purchase
      agreement or related agreements;

o     if we or any of our  subsidiaries  make an  assignment  for the benefit of
      creditors or become involved in bankruptcy, insolvency,  reorganization or
      liquidation proceedings;

o     if we merge out of existence  without the surviving  company  assuming the
      obligations relating to the Series Q Preferred Stock;

o     if our common stock is no longer listed on the Nasdaq National Market, the
      Nasdaq SmallCap Market, the NYSE or the AMEX;

o     if the Series Q Preferred Stock is no longer convertible into common stock
      because it would  result in an aggregate  issuance of more than  3,434,581
      shares of common  stock,  as such number may be adjusted,  and we have not
      waived such limit or obtained stockholder approval of a higher limit; or

o     if the Series Q Preferred Stock is no longer convertible into common stock
      because it would  result in an aggregate  issuance of more than  7,157,063
      shares of our common  stock (the  maximum  share  amount will  increase to
      9,365,463  shares of our common stock if we receive written  guidance from
      Nasdaq that the issuance of the Series Q Preferred  Stock and the Series Q
      Warrants  will not be  integrated  with the issuances of the January Stock
      and  Warrants) and we have not obtained  stockholder  approval of a higher
      limit.

         The  foregoing  description  of the Series Q  Preferred  Stock  private
placement  does not purport to be complete  and is  qualified in its entirety by
reference to (a) the  Certificate  of  Designations,  Rights and  Preferences of
Series Q Convertible  Preferred Stock, filed as Exhibit 4.1 hereto, (b) the form
of  Warrant,  filed as  Exhibit  4.2  hereto,  and (c) the  Securities  Purchase
Agreement, filed as Exhibit 10.1 hereto, each of which is incorporated herein by
reference.

(c)      Exhibits.

      4.1  Certificate  of  Designations,  Preferences,  and  Rights of Series Q
           Convertible Preferred Stock of eGlobe.

      4.2  Form of Warrant to purchase  100,000  shares of eGlobe  common stock,
           dated March 15, 2000.

      10.1 Securities Purchase Agreement,  dated March 15, 2000, between eGlobe,
           Inc. and RGC International Investors, LDC.



<PAGE>


                                    SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                          eGLOBE, INC.


Date:  March __, 2000                     By:           /s/
                                                    -----------------------
                                                   Graeme S.R. Brown
                                                    Deputy General Counsel
                                                       and Secretary



<PAGE>


                                  EXHIBIT INDEX


   Exhibit                                   Description

      4.1  Certificate  of  Designations,  Preferences,  and  Rights of Series Q
           Convertible Preferred Stock of eGlobe.

      4.2  Form of Warrant to purchase  100,000  shares of eGlobe  common stock,
           dated March 15, 2000.

      10.1 Securities Purchase Agreement,  dated March 15, 2000, between eGlobe,
           Inc. and RGC International Investors, LDC.
[{"type": "8-K", "sequence": "1", "description": "FORM 8-K", "secsgml_size_bytes": 8671}]
{"company-data": {"conformed-name": "EGLOBE INC", "cik": "0000842807", "assigned-sic": "7389", "irs-number": "133486421", "state-of-incorporation": "DE", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-10210", "film-number": "576374"}, "business-address": {"street1": "1250 24TH STREET NW", "street2": "SUITE 725", "city": "WASHINGTON", "state": "DC", "zip": "20037", "phone": "3036912115"}, "mail-address": {"street1": "1250 24TH STREET NW", "street2": "SUITE 725", "city": "WASHINGTON", "state": "DC", "zip": "20037"}, "former-company": {"former-conformed-name": "EXECUTIVE TELECARD LTD", "date-changed": "19920703"}}
SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

   Date of Report (Date of                             Commission File Number:
  earliest event reported):

        MARCH 17, 2000                                         1-10210

                                  EGLOBE, INC.
             (Exact name of registrant as specified in its charter)

          DELAWARE                                        13-3486421
 (State or other jurisdiction of                  (IRS Employer Identification
          incorporation)                                    Number)

                         1250 24TH STREET, NW, SUITE 725
                             WASHINGTON, D.C. 20037
               (Address of principal executive offices) (Zip Code)

               Registrant's telephone number, including area code:
                                 (202) 822-8981

          (Former name or former address, if changed since last report)

                                       NA
EGLOBE, INC.

ITEM 5            OTHER EVENTS

         On March 17, 2000, we closed a $4 million equity private placement with
RGC International Investors, LDC ("RGC"), which made a $15 million investment in
us on  January  26,  2000.  Pursuant  to  the  terms  of a  securities  purchase
agreement,  we issued  RGC 4,000  shares of our Series Q  convertible  preferred
stock (the "Series Q Preferred Stock") and warrants (the "Series Q Warrants") to
purchase  100,000  shares of our common  stock with a per share  exercise  price
equal to $12.04,  subject to  adjustment  for  issuances of shares of our common
stock below market price. We intend to use the proceeds of the private placement
for general working capital.

         The Series Q securities  purchase  agreement  also provides that we may
issue up to 6,000 additional shares of our Series Q Preferred Stock and warrants
to  purchase  an  additional  150,000  shares of our common  stock to RGC for an
additional $6,000,000 at a second closing to be completed no later than July 15,
2000.  The primary  condition to the second  closing is the  effectiveness  of a
registration  statement  registering  the resale of common stock  underlying the
Series Q Preferred  Stock and the Series Q Warrants and the preferred  stock and
warrants issued in January (the "January Stock and Warrants").

         The shares of Series Q Preferred Stock carry an effective  annual yield
of 5% (payable in kind at the time of conversion)  and are  convertible,  at the
holder's  option,  into shares of common stock. The shares of Series Q Preferred
Stock will  automatically  be converted into shares of common stock on March 15,
2003, subject to delay for specified events. The conversion price for the Series
Q Preferred Stock is $12.04 until April 26, 2000, and thereafter is equal to the
lesser of:

o     the five day average  closing  price of our common stock on Nasdaq  during
      the 22-day period prior to conversion, and

o     $12.04.

We can force a  conversion  of the Series Q  Preferred  Stock on any trading day
following a period in which the  closing bid price of our common  stock has been
greater  than $24.08 for a period of at least 20 trading  days after the earlier
of:

o     the  first  anniversary  of  the  date  the  common  stock  issuable  upon
      conversion  of the  Series Q  Preferred  Stock and  Series Q  Warrants  is
      registered for resale, and

o     the  completion of a firm  commitment  underwritten  public  offering with
      gross proceeds to us of at least $45 million.

         The Series Q Preferred Stock is convertible into a maximum of 3,434,581
shares of common stock.  This maximum share amount is subject to increase if the
average closing bid prices of our common stock for the 20 trading days ending on
the later of June 30,  2000 and the 60th  calendar  day after the  common  stock
issuable upon  conversion of the Series Q Preferred  Stock and Series Q Warrants
is registered is less than $9.375, provided that under no circumstances will the
Series Q Preferred Stock be convertible  into more than 7,157,063  shares of our
common stock (the maximum share amount will increase to 9,365,463  shares of our
common stock if we receive written guidance from Nasdaq that the issuance of the
Series Q Preferred  Stock and the Series Q Warrants will not be integrated  with
the issuances of the January  Stock and  Warrants).  In addition,  no holder may
convert the Series Q Preferred  Stock or exercise  the Series Q Warrants it owns
for any  shares  of common  stock  that  would  cause it to own  following  such
conversion  or exercise in excess of 4.9% of the shares of our common stock then
outstanding.
We may be required to redeem the Series Q Preferred Stock under certain
circumstances:

o     if we fail to perform specified  obligations under the securities purchase
      agreement or related agreements;

o     if we or any of our  subsidiaries  make an  assignment  for the benefit of
      creditors or become involved in bankruptcy, insolvency,  reorganization or
      liquidation proceedings;

o     if we merge out of existence  without the surviving  company  assuming the
      obligations relating to the Series Q Preferred Stock;

o     if our common stock is no longer listed on the Nasdaq National Market, the
      Nasdaq SmallCap Market, the NYSE or the AMEX;

o     if the Series Q Preferred Stock is no longer convertible into common stock
      because it would  result in an aggregate  issuance of more than  3,434,581
      shares of common  stock,  as such number may be adjusted,  and we have not
      waived such limit or obtained stockholder approval of a higher limit; or

o     if the Series Q Preferred Stock is no longer convertible into common stock
      because it would  result in an aggregate  issuance of more than  7,157,063
      shares of our common  stock (the  maximum  share  amount will  increase to
      9,365,463  shares of our common stock if we receive written  guidance from
      Nasdaq that the issuance of the Series Q Preferred  Stock and the Series Q
      Warrants  will not be  integrated  with the issuances of the January Stock
      and  Warrants) and we have not obtained  stockholder  approval of a higher
      limit.

         The  foregoing  description  of the Series Q  Preferred  Stock  private
placement  does not purport to be complete  and is  qualified in its entirety by
reference to (a) the  Certificate  of  Designations,  Rights and  Preferences of
Series Q Convertible  Preferred Stock, filed as Exhibit 4.1 hereto, (b) the form
of  Warrant,  filed as  Exhibit  4.2  hereto,  and (c) the  Securities  Purchase
Agreement, filed as Exhibit 10.1 hereto, each of which is incorporated herein by
reference.

(c)      Exhibits.

      4.1  Certificate  of  Designations,  Preferences,  and  Rights of Series Q
           Convertible Preferred Stock of eGlobe.

      4.2  Form of Warrant to purchase  100,000  shares of eGlobe  common stock,
           dated March 15, 2000.

      10.1 Securities Purchase Agreement,  dated March 15, 2000, between eGlobe,
           Inc. and RGC International Investors, LDC.
SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                          eGLOBE, INC.

Date:  March __, 2000                     By:           /s/
                                                    -----------------------
                                                   Graeme S.R. Brown
                                                    Deputy General Counsel
                                                       and Secretary
EXHIBIT INDEX

   Exhibit                                   Description

      4.1  Certificate  of  Designations,  Preferences,  and  Rights of Series Q
           Convertible Preferred Stock of eGlobe.

      4.2  Form of Warrant to purchase  100,000  shares of eGlobe  common stock,
           dated March 15, 2000.

      10.1 Securities Purchase Agreement,  dated March 15, 2000, between eGlobe,
           Inc. and RGC International Investors, LDC.